Scarica l'app Stockscreener
6.53
2.62%
-0.16
Dopo l'orario di chiusura:
6.53
Precedente Chiudi:
$6.69
Aprire:
$6.69
Volume 24 ore:
193.99K
Relative Volume:
1.25
Capitalizzazione di mercato:
$244.46M
Reddito:
$128.45M
Utile/perdita netta:
$6.54M
Rapporto P/E:
130.60
EPS:
0.05
Flusso di cassa netto:
$-8.79M
1 W Prestazione:
-1.73%
1M Prestazione:
-17.11%
6M Prestazione:
+2.84%
1 anno Prestazione:
+41.32%
Intervallo 1D:
$6.50
$6.8099
Intervallo di 1 settimana:
$6.33
$7.0099
Portata 52W:
$4.5903
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Nome
Lifecore Biomedical Inc
Settore
Telefono
(952) 368-4300
Indirizzo
3515 LYMAN BOULEVARD, CHASKA
Confronta LFCR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
6.53 | 245.03M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
143.24 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.89 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.185 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.62 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
432.69 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | Iniziato | William Blair | Outperform |
| 2024-09-05 | Iniziato | Craig Hallum | Buy |
| 2024-08-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie
Is it too late to sell Lifecore Biomedical Inc.Market Trend Review & Free Daily Entry Point Trade Alerts - newser.com
How high can Lifecore Biomedical Inc. stock go2025 Valuation Update & Advanced Technical Analysis Signals - newser.com
Will Lifecore Biomedical Inc. (LDE) stock deliver compounding returns2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com
Why pension funds invest in Lifecore Biomedical Inc. (LDE) stock2025 Price Targets & Entry Point Confirmation Alerts - newser.com
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events - GlobeNewswire
Best data tools to analyze Lifecore Biomedical Inc. stockPortfolio Risk Summary & Safe Swing Trade Setup Alerts - newser.com
What catalysts could drive Lifecore Biomedical Inc. stock higherWeekly Investment Report & Verified Swing Trading Watchlist - newser.com
Can Lifecore Biomedical Inc. stock beat market expectations this quarterSell Signal & Daily Oversold Stock Bounce Ideas - newser.com
3 Events: Lifecore to Present at PODD, CPHI Frankfurt & Pharma Outsourcing Summit Oct–Nov 2025 - Stock Titan
Is it time to cut losses on Lifecore Biomedical Inc.2025 Momentum Check & Smart Money Movement Tracker - newser.com
Will Lifecore Biomedical Inc. bounce back from current supportQuarterly Earnings Summary & High Yield Stock Recommendations - newser.com
Chart overlay techniques for tracking Lifecore Biomedical Inc.2025 Geopolitical Influence & Community Verified Trade Signals - newser.com
How Lifecore Biomedical Inc. (LDE) stock compares with market leadersTrade Entry Report & Fast Exit and Entry Strategy Plans - newser.com
Analyzing net buyer seller activity in Lifecore Biomedical Inc.2025 Risk Factors & Weekly Hot Stock Watchlists - newser.com
With 45% stake, Lifecore Biomedical, Inc. (NASDAQ:LFCR) seems to have captured hedge funds investors' interest - Yahoo Finance
Rating Downgrade: Lifecore, Ready To Go, But Problems Remain (NASDAQ:LFCR) - Seeking Alpha
CEO Insights: Industry Trends Driving Strong Tailwinds for U.S.-based CDMOs - Contract Pharma
Using fundamentals and technicals on Lifecore Biomedical Inc.Swing Trade & Weekly Watchlist for Hot Stocks - newser.com
Real time alert setup for Lifecore Biomedical Inc. performanceQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Published on: 2025-10-05 05:34:33 - newser.com
Lifecore granted Sector Weight rating at KeyBanc on growth trajectory - MSN
Can volume confirm reversal in Lifecore Biomedical Inc.Market Trend Report & AI Driven Price Forecasts - newser.com
Is Lifecore Biomedical Inc. (LDE) stock suitable for passive index funds2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Quantitative breakdown of Lifecore Biomedical Inc. recent moveOil Prices & Real-Time Stock Entry Alerts - newser.com
LIFECORE SHAREHOLDER ALERT: Kaskela Law LLC Announces - GlobeNewswire
What drives Lifecore Biomedical Inc stock priceStock Buy Signals & Big Returns, Small Investment – Learn How - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Lifecore Biomedical Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
What analysts say about Lifecore Biomedical Inc LDE stockStraddle and Strangle Trades & Free Stock Education Platform for New Investors - earlytimes.in
What analysts say about Lifecore Biomedical Inc stockMarket Correction Analysis & High Profit Market Growth - earlytimes.in
Is Lifecore Biomedical Inc a good long term investmentTechnical Analysis Insights & Learn to Trade with Real-Time Feedback - earlytimes.in
Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lifecore Biomedical Inc Azioni (LFCR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| English Aron R. | 10% Owner |
May 28 '25 |
Sale |
7.12 |
150,419 |
1,071,555 |
264,180 |
| English Aron R. | 10% Owner |
May 23 '25 |
Sale |
6.75 |
96,137 |
649,386 |
1,554,103 |
| English Aron R. | 10% Owner |
May 13 '25 |
Sale |
7.00 |
12,334 |
86,353 |
1,650,240 |
| English Aron R. | 10% Owner |
May 12 '25 |
Sale |
7.03 |
45,698 |
321,426 |
1,662,574 |
| English Aron R. | 10% Owner |
May 08 '25 |
Sale |
7.00 |
5,098 |
35,693 |
1,708,972 |
| English Aron R. | 10% Owner |
May 09 '25 |
Sale |
7.00 |
700 |
4,900 |
1,708,272 |
| English Aron R. | 10% Owner |
May 05 '25 |
Sale |
7.08 |
24,543 |
173,831 |
1,730,618 |
| English Aron R. | 10% Owner |
May 07 '25 |
Sale |
7.01 |
15,847 |
111,099 |
1,714,070 |
| English Aron R. | 10% Owner |
May 06 '25 |
Sale |
7.05 |
701 |
4,940 |
1,729,917 |
| Josephs Paul | Chief Executive Officer |
Jan 08 '25 |
Buy |
5.74 |
17,000 |
97,580 |
559,717 |
0.02%
5.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):